Peptidergic and catecholaminergic mechanisms in central blood pressure control.
D000804:Angiotensin II / Q000502:physiology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism / Q000502:physiology*; D004195:Disease Models, Animal; D004837:Epinephrine / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000378:metabolism; D007705:Kinins / Q000502:physiology; D018377:Neurotransmitter Agents / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology; D010455:Peptides / Q000378:metabolism / Q000502:physiology*; D011311:Pressoreceptors / Q000502:physiology; D051381:Rats; D013373:Substance P / Q000502:physiology
D002395:Catecholamines; D007705:Kinins; D018377:Neurotransmitter Agents; D010455:Peptides; D000804:Angiotensin II; D013373:Substance P; D009638:Norepinephrine; D004837:Epinephrine